Media coverage

Applied Cannabis Research Media

CMos study media
04
Nov

The CMOS is expected to run for five years

The CMOS is expected to run for five years, with patients to be recruited nationwide via medical centers, prescribing GP’s, and specialists. Earlier today the specialist contract research organisation Applied Cannabis Research (ACR)—which operates as a division of Southern Cannabis Holdings—announced the official launch of the largest medicinal cannabis study in Australian history. Applied Cannabis Research will...
Read More
Medical cannabis study Australia
26
Oct

News Release: Joining forces for the largest medical cannabis study in Australia

Australia’s Largest Medicinal Cannabis Study To Date Applied Cannabis Research, Industry Heavyweights and Nationwide Medical Networks Join Forces For a Study of 20,000 Patients, Applied Cannabis Research​ (ACR), a Southern Cannabis Holdings company, is extremely excited to announce that it is launching Australia’s largest observational study ever undertaken for medical cannabis. ACR will lead the...
Read More
Doctor_cannabis
21
Feb

Is Cannabis the Solution to the Chronic Pain Crisis?

The GreenFund – A new study has found that medicinal cannabis may be able to reduce the intensity of chronic pain in patients by as much as 30%. A new study conducted by Southern Cannabis Holdings (SCH) has found that medicinal cannabis may be a highly effective treatment option for patients suffering from chronic pain....
Read More
Applied cannabis research - mgc pharma
21
Feb

Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug

STOCKHEAD MGC (ASX:MXC) will conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia, a direct comparison assessing the efficacy of low-THC to 100 per cent CBD products when treating severe intractable epilepsy. Read more : Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug
Read More
CURRENT CLINICAL TRIALS OF Medicinal cannabis in Australia
20
Feb

Applied Cannabis Research Launches Appetite Stimulation Study

The study will be conducted in collaboration with CA Clinics and is one of the first of its kind globally. A new study aimed at assessing the efficacy of THC-based medications for sufferers of cachexia was launched this week by Applied Cannabis Research (ACR), a division of Southern Cannabis Holdings (SCH). Read more: Applied Cannabis...
Read More